Mahamaya Lifesciences IPO Details
| IPO Open Date | November 11, 2025 |
| IPO Close Date | November 13, 2025 |
| Face Value | ā¹10 Per Equity Share |
| IPO Price Band | ā¹108 to ā¹114 Per Share |
| Issue Size | Approx ā¹70.44 Crores |
| Fresh Issue | Approx ā¹64.28 Crores |
| Offer for Sale: | Approx 5,40,000 Equity Shares |
| Issue Type | Book Built Issue |
| IPO Listing | BSE SME |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Mahamaya Lifesciences IPO Review & Key Points
- Review: Neutral
Mahamaya Lifesciences IPO Market Lot
The Mahamaya Lifesciences IPO minimum market lot is 2,400 shares with ā¹2,73,600 application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 2,400 | ā¹2,73,600 |
| Retail Maximum | 2 | 2,400 | ā¹2,73,600 |
| S-HNI Minimum | 3 | 3,600 | ā¹4,10,400 |
| S-HNI Maximum | 7 | 8,400 | ā¹9,57,600 |
| B-HNI Minimum | 8 | 9,600 | ā¹10,94,400 |
IPO Reservation
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | 17,52,000 Shares | 28.36% |
| QIB (Ex. Anchor) | 11,76,000 Shares | 19.03% |
| NII Shares Offered | 8,82,000 Shares | 14.27% |
| Retail Shares Offered | 20,59,200 Shares | 33.33% |
Mahamaya Lifesciences IPO Anchor Investors
| Anchor Bidding Date | November 10, 2025 |
| Anchor Investors List | |
| Shares Offered | 17,52,000 Shares |
| Anchor Size | 19.97 Cr. |
| lock-in period end date 50% shares (30 Days) | December 14, 2025 |
| lock-in period end date 50% shares (90 Days) | February 12, 2026 |
Mahamaya Lifesciences IPO Dates
The Mahamaya Lifesciences IPO date is November 11 and the close date is November 13. The Mahamaya Lifesciences IPO allotment will be finalized on November 14 and the IPO listing on November 18.
| IPO Open Date: | November 11, 2025 |
| IPO Close Date: | November 13, 2025 |
| Basis of Allotment: | November 14, 2025 |
| Refunds: | November 17, 2025 |
| Credit to Demat Account: | November 17, 2025 |
| IPO Listing Date: | November 18, 2025 |
| IPO Bidding Cut-off Time: | November 13, 2025 – 5 PM |
Promoters and Holding Pattern
The promoters of the company are Mr. Krishnamurthy Ganesan, Mr. Prashant Krishnamurthy, and Mrs. Lalitha Krishnamurthy.
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 1,77,66,200 | 77.27% |
| Promoter Holding Post Issue | 2,34,05,000 | 56.35% |
Objects of the Issue & Utilisation of proceeds
| Purpose | Crores |
| Purchase of Equipment for existing Formulation plant. | ā¹3.75 |
| Funding capital expenditure towards setting up of a new Technical manufacturing plant. | ā¹29.42 |
| Construction of Warehouse Building and Purchase of Machinery. | ā¹2.53 |
| Funding working capital requirement of the Company. | ā¹18.00 |
| General Corporate purposes. | ā¹- |
About Mahamaya Lifesciences IPO
Mahamaya Lifesciences Limited, founded in 2002, is one of the leading companies that focuses on the manufacturing of pesticide formulations and supplies bulk formulations. By working with the Central Insecticides Board and Registration Committee (CIBRC), the company started its business with the import and registration of major pesticide molecules that were not produced in India. After successful registration, they decided to market these molecules as technical products to both Indian agrochemical companies as well as multinational corporations (MNCs).
Since its incorporation in 2002, the company has grown significantly by setting up its own manufacturing plant in December 2021 at Dahej, Gujarat. Its product has reached various states like Punjab, Haryana, Rajasthan, Uttar Pradesh, Gujarat, Maharashtra, Andhra Pradesh, and Telangana in India, while internationally they export their products to Turkey, Egypt, and the UAE.
Mahamaya Lifesciences IPO Company Financial Report
Amount ā¹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ā¹137.40 | ā¹132.30 | ā¹3.75 | ā¹77.88 |
| 2024 | ā¹162.83 | ā¹155.71 | ā¹5.22 | ā¹112.07 |
| 2025 | ā¹267.17 | ā¹249.81 | ā¹12.94 | ā¹188.35 |
| June 2025 | ā¹84.04 | ā¹78.35 | ā¹4.10 | ā¹218.87 |
Mahamaya Lifesciences IPO Valuation – FY2025
Check Mahamaya Lifesciences IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 34.94% |
| ROCE: | 23.15% |
| EBITDA Margin: | 9.22% |
| PAT Margin: | 4.84% |
| Debt to equity ratio: | 1.08 |
| Earning Per Share (EPS): | ā¹7.60 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 26.19% |
| Net Asset Value (NAV): | ā¹27.82 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Nova Agritech Limited | 3.05 | 16.93 | 12.47% | 23.76 | 296.60 Cr. |
| Bhagiradha Chemicals & Industries Limited | 1.14 | 247.63 | 2.03% | 52.61 | 449.75 Cr. |
IPO Lead Managers aka Merchant Bankers
- Oneview Corporate Advisors Pvt.Ltd.
Company Address
Mahamaya Lifesciences Ltd.
Unit No: DPT ā 033, Ground Floor,
Plot No: 79 ā 80, DLF Prime Tower,
Block, Okhla, Phase ā 1
Delhi, New Delhi, 110020
Phone: +91-1146561474
Email: [email protected]
Website: https://www.mahamayalifesciences.com/
IPO Registrar
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: [email protected]
Website: https://ipostatus.kfintech.com/
Mahamaya Lifesciences IPO FAQs
What is Mahamaya Lifesciences IPO?
When Mahamaya Lifesciences IPO will open for subscription?
What is Mahamaya Lifesciences IPO Investors Portion?
How to Apply the Mahamaya Lifesciences IPO?
What is Mahamaya Lifesciences IPO Issue Size?
What is Mahamaya Lifesciences IPO Price Band?
What is Mahamaya Lifesciences IPO Lot Size?
What is the Mahamaya Lifesciences IPO Allotment Date?
What is the Mahamaya Lifesciences IPO Listing Date?
Note: The Mahamaya Lifesciences IPO price band and date are officially announced. The (Mahamaya Lifesciences IPO grey market premium) will be added to the IPO GMP page as it will start).
